BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9395118)

  • 1. Oral mucosal side effects of cytotoxic chemotherapy of testicular cancer. A retrospective study.
    Herlofson BB; Norman-Pedersen K; Redfors M; Fosså SD
    Eur J Oral Sci; 1997 Oct; 105(5 Pt 2):523-6. PubMed ID: 9395118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of pneumomediastinum during BEP (bleomycin, etoposide, cisplatin) chemotherapy for testicular cancer].
    Noguchi G; Ota J; Ishigaki H; Onuki T; Kato Y; Moriyama M
    Hinyokika Kiyo; 2013 Aug; 59(8):545-9. PubMed ID: 23995535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumors.
    Culine S; Theodore C; Farhat F; Bekradda M; Terrier-Lacombe MJ; Droz JP
    J Surg Oncol; 1996 Mar; 61(3):195-8. PubMed ID: 8637206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma.
    Glisson B; Lee JS; Palmer J; Fossella F; Shin DM; Murphy WK; Perez-Soler R; Hong WK
    Cancer; 1998 Jan; 82(2):301-8. PubMed ID: 9445186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etoposide-cisplatin and thoracic radiation therapy salvage of incomplete responders to a noncisplatin induction regimen for limited and extensive small-cell carcinoma of the lung.
    Shaw EG; Frytak S; Eagan RT; Richardson RL; Creagan ET; Jett JR; Foote RL; Su JQ; Schaid DJ; Lee RE
    Am J Clin Oncol; 1996 Apr; 19(2):154-8. PubMed ID: 8610640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrovascular accident after chemotherapy for testicular cancer.
    Karagoz B; Bilgi O; Akyol I; Ozgun A; Turken O; Kandemir EG
    Mil Med; 2009 Mar; 174(3):320-1. PubMed ID: 19354100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The safety of combination chemotherapy with ifosfamide, cisplatin, and etoposide (ICE): single-institution retrospective review of 108 cases].
    Kanamori M; Kumabe T; Saito R; Yamashita Y; Sonoda Y; Tominaga T
    No Shinkei Geka; 2010 Nov; 38(11):997-1005. PubMed ID: 21081811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.
    Musolino A; Perrone MA; Michiara M; Delnevo D; Franciosi V; Di Blasio B; Ceci G; Camisa R; Ardizzoni A; Cocconi G
    Cancer; 2005 May; 103(10):2109-17. PubMed ID: 15803492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bleomycin-induced pneumonia].
    Berger K; Göpfert A; Berkel H
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Nov; 31(9):577-81. PubMed ID: 9063925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for AIDS-related and endemic African Kaposi's sarcoma in southern Africa.
    Stein ME; Lachter J; Spencer D; Bezwoda WR
    Int J Dermatol; 1995 Oct; 34(10):729-32. PubMed ID: 8537166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncological outcomes of metastatic testicular cancers under centralized management through regional medical network.
    Inai H; Kawai K; Kojima T; Joraku A; Shimazui T; Yamauchi A; Miyagawa T; Endo T; Fukuhara Y; Miyazaki J; Uchida K; Nishiyama H
    Jpn J Clin Oncol; 2013 Dec; 43(12):1249-54. PubMed ID: 24101656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future trials in germ cell malignancy (GCM) of the testis.
    Oliver RT
    Eur J Surg Oncol; 1997 Apr; 23(2):117-22. PubMed ID: 9158184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
    Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
    J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ifosfamide in the treatment of germ cell tumors.
    Nichols CR
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):65-73. PubMed ID: 8677452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.
    Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS
    J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer.
    Broun ER; Nichols CR; Gize G; Cornetta K; Hromas RA; Schacht B; Einhorn LH
    Cancer; 1997 Apr; 79(8):1605-10. PubMed ID: 9118046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy for testicular cancer.
    Xiao H; Sheinfeld J; Motzer RJ
    Surg Oncol Clin N Am; 1997 Oct; 6(4):863-78. PubMed ID: 9309098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma.
    Kim DW; Jo YH; Kim JH; Wu HG; Rhee CS; Lee CH; Kim TY; Heo DS; Bang YJ; Kim NK
    Cancer; 2004 Nov; 101(10):2257-60. PubMed ID: 15484215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The modification of the toxicity produced by chemotherapy in testicular cancer by adapting its intensity to prognostic groups].
    Blanco Guerrero R; Germà Lluch JR; Climent Durán MA; Mercedes Ramírez A; Alonso Muñoz C; López Pousa A; López López JJ
    Med Clin (Barc); 1991 Oct; 97(13):491-4. PubMed ID: 1721988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
    Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
    J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.